CRISPR Therapeutics AGCRISPR Therapeutics AGCRISPR Therapeutics AG

CRISPR Therapeutics AG

No trades
See on Supercharts

Key facts today

CRISPR Therapeutics AG posted a Q3 net loss of $1.01 per share, better than last year's $1.41. Revenue for the quarter was $602,000, up from no revenue in the same period last year.
Analyze the impactAnalyze the impact

See all ideas 

Displays a symbol's price movements over previous years to identify recurring trends.